Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 16/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8952307 | 0.98 | CRBN (0.43) | CRBNDDB1POLBKMT2A | |
| SCHEMBL20359431 | 0.94 | CRBN (0.44) | CRBNDDB1POLBKMT2A | |
| SCHEMBL20206912 | 0.87 | CRBN (0.46) | CRBNDDB1 | |
| SCHEMBL8952198 | 0.81 | POLB (0.41) | CRBNDDB1POLBKMT2A | |
| SCHEMBL18379287 | 0.79 | POLB (0.54) | CRBNDDB1POLBKMT2A | |
| SCHEMBL732924 | 0.79 | POLB (0.54) | CRBNDDB1POLBKMT2A | |
| SCHEMBL732367 | 0.79 | POLB (0.54) | CRBNDDB1POLBKMT2A | |
| SCHEMBL3042782 | 0.78 | FAAH (0.44) | CRBNDDB1 | |
| Acrylic Acid SCHEMBL31065402 | 0.77 | POLB (0.44) | CRBNDDB1POLBKMT2A | |
| SCHEMBL723934 | 0.77 | POLB (0.55) | CRBNDDB1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0662834-A4 | NOVEL EPOXIDE-CONTAINING COMPOUNDS. | CELL THERAPEUTICS INC (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0662834-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994006431-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-03-31 | — | — | WO | disclosed |